Prevalence, prescriptions, outcomes and costs of type 2 diabetic patients with or without prior coronary artery disease or stroke. A longitudinal 5-year claims-data analysis of over 7 million inhabitants

Study identification

• EU PAS number:
  EUPAS1000000257
• Study ID:
  1000000257
• Official title and acronym:
  Prevalence, prescriptions, outcomes and costs of type 2 diabetic patients with or without prior coronary artery disease or stroke. A longitudinal 5-year claims-data analysis of over 7 million inhabitants
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  Retrospective observational cohort study providing a descriptive analysis of prevalence, comorbidities, outcomes and costs of type 2 diabetes mellitus patients with and without coronary artery disease (CAD) or stroke in the ReS database.
• Study status:
  Finalised

Research institutions and networks

Institutions

Fondazione ReS (Ricerca e Salute), CINECA partner

Italy

Study timelines

Date when funding contract was signed

Actual:12/07/2019

Study start date

Actual:02/09/2019

Date of final study report

Actual:12/03/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Astra Zeneca SpA

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable